Epigenetics Market

Epigenetics Market by Product (Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology, Immunology), Technology (DNA Methylation, Histone Modification), End User (Academic, CRO) - Global Forecast to 2022

Report Code: BT 2775 Oct, 2019, by marketsandmarkets.com
Updated date -

[230 Pages Report] The global epigenetics market is projected to reach USD 1.60 billion by 2022 from USD 0.85 billion in 2016, at a CAGR of 13.3% from 2017 to 2022. The growth in this market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the market in the coming years. The base year considered for the study is 2016, and the forecast has been provided for the period between 2017 and 2022.

Selected Market Dynamics in Epigenetics Market

Rising cancer prevalence

Globally, there has been a significant increase in the number of people suffering from cancer. According to WHO estimates, the number of people suffering from cancer is expected to increase to 19.3 million by 2025 from 14.1 million in 2012. Cancer is the second leading cause of death in the US and accounts for nearly 1 in every 4 deaths. According to the American Cancer Society, in the US, the number of new cancer cases (excluding carcinoma in situ of any site) is expected to increase to 1,688,780 in 2017 from 1,685,210 in 2016, while the total number of cancer-related deaths will increase to 600,920 from 595,690 during the same period.

Epigenetic changes such as dysregulation of DNA methylation are associated with cancer development and progression. Epigenetics provides new opportunities for deriving therapeutic strategies designed to reverse dysregulation in cancer. Several cancer research studies that utilize epigenetics techniques are currently underway; significant investments are being made to support these researches. For instance, in February 2016, the University of Southampton and University Hospitals Southampton NHS Foundation Trust (UK) received USD 1.57 million (GBP 1 million) for genetics and genomics research related to cancer and infectious diseases. Similarly, in March 2015, Barts Cancer Institute’s Centre for Haemato-Oncology (UK) received funds worth USD 113.9 million (GBP 860,000) from the Medical Research Council to study epigenetics changes in cancer. The increasing prevalence of cancer will drive epigenetics research focused on this condition.

High cost of instruments

Instruments required for epigenetics research are expensive as they are equipped with advanced features and functionalities. For instance, Illumina’s NovaSeq 5000 and 6000 sequencers (launched in January 2017) are priced at USD 850,000 and USD 985,000, respectively. In addition, maintenance and several other indirect expenses, such as sample and consumables, further increase the overall cost of ownership.

Pharmaceutical companies and research laboratories require many such systems. Therefore, significant investments are required for procuring multiple, high-cost genomic instruments. End users such as academic research laboratories find it difficult to afford such systems as they have constricted budgets. High instrument costs, therefore, hinder their wide adoption, which is expected to restrict market growth during the forecast period.

The following are the major objectives of the study.

  • To define, describe, and forecast the global epigenetics market by product, application, technology, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
  • To forecast the size of the epigenetics market, with respect to fiver main regions—North America, Europe, Asia Pacific (APAC), Latin America, and Middle East & Africa
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To profile the key players and comprehensively analyze their core competencies2 in terms of key market developments, product portfolios, market share analysis, and financials
  • To track and analyze competitive developments such as agreements, acquisitions, product launches, and R&D activities of leading players in the global market

 During this research study, major players operating in the epigenetics market in various regions have been identified, and their offerings, regional presence, and distribution channels have been analyzed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Factiva, along with primary respondents. The entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) pertaining to the market. The figure below shows the breakdown of the primaries on the basis of the company type, designation, and region considered during the research study.

Epigenetics Technologies Market - Breakdown of Primary Participants

To know about the assumptions considered for the study, download the pdf brochure

The epigenetics market is fragmented with a large number of players offering a variety of products. The prominent players in the global market are Illumina (US), Thermo Fisher Scientific (US), Merck Millipore (US), Abcam (UK), Active Motif (US), Bio-Rad Laboratories (US), New England Biolabs (US), Agilent (US), QIAGEN (Netherlands), Zymo Research (US), PerkinElmer (US), and Diagenode (Belgium).

Major Market Developments

  • In July 2017, Agilent launched AriaDx Real-Time PCR System
  • In June 2017, Illumina launched Extended RAS Panel, a NGS kit
  • In January 2017, Illumina entered into an agreement with Koninklijke Philips (Netherlands) to integrate Ilumina’s sequencing systems with Philips’ IntelliSpace Genomics clinical informatics platform for oncology

Target Audience

  • Manufacturers and vendors of epigenetics products
  • Academic and research institutes
  • Contract research organizations (CROs)
  • Pharmaceutical and biotechnology companies
  • Research and consulting firms
  • Venture capitalists

Report Scope

By Product

  • Enzymes
    • DNA-modifying Enzymes
    • Protein-modifying Enzymes
    • RNA-modifying Enzymes
  • Instruments and Consumables
    • Next-generation Sequencers
    • qPCR
    • Mass Spectrometers
    • Sonicators
    • Others
  • Kits
    • Bisulfite Conversion Kits
    • ChIP-sequencing Kits
    • RNA sequencing Kits
    • Whole Genomic Amplification Kits
    • 5-hmC and 5-mC Analysis Kits
    • Others
  • Reagents
    • Antibodies
    • Buffers
    • Histones
    • Magnetic Beads
    • Primers
    • Others
  • Bioinformatics Tools

By Application

  • Oncology
  • Metabolic Diseases
  • Developmental Biology
  • Immunology
  • Cardiovascular Diseases
  • Others

By Technology

  • DNA Methylation
  • Histone Modifications
  • Others

By End User

  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Latin America
  • Middle East and Africa

Critical questions which the report answers

  • What are new application areas which the Reed Sensor companies are exploring?
  • Which are the key players in the market and how intense is the competition?

Available Customizations

Based on the given market data, MarketsandMarkets offers customizations in the reports as per the client’s specific requirements. The available customization options are as follows:

Geographic Analysis

  • Further breakdown of the Rest of Asia-Pacific market into Australia, New Zealand, and others
  • Further breakdown of the Rest of Europe market into Belgium, Russia, Netherlands, Switzerland, and others
  • Further breakdown of the Latin American epigenetics devices market into Brazil, Mexico, and others

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

The global epigenetics market is projected to reach USD 1.60 billion by 2022 from USD 0.85 billion in 2017, growing at a CAGR of 13.3% during the forecast period. Decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases are the factors contributing for the growth of this market.

Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, and changes in lifestyle.

The report analyzes the global market by product, applictaion, technology, end user, and region. Based on product, the global epigenetics market is segmented into enzymes, instruments and consumables, kits, reagents and bioinformatics tools. By product, the market is segmented into kits, reagents, enzymes, instruments & consumables, and bioinformatics tools. The kits segment is expected to grow at the highest CAGR of 16.2% from 2017-2022 due to the fact that a large number of kits are used in various epigenetics techniques. The rising prevalence of a number of diseases, increasing R&D spending, and growing government funding for life science research are further contributing to market growth in this segment.

The epigenetics market in Asia-Pacific region is expected to witness the highest CAGR during the forecast period of 2017 to 2022. The growth of this segment can be attributed to the increasing R&D spending, increasing government initiatives, and rising focus on key market players in the region. Emerging markets such as Brazil, China, and India offer significant growth potential to market players. This can primarily be attributed to the diversified healthcare market in this region, growing incidence of infectious and chronic disorders, and increasing R&D initiatives targeted at the development of innovative genomic techniques. In addition, developments in research infrastructure, increasing R&D expenditure, low labor cost, and rapid growth in the number of CROs and pharmaceutical industry are encouraging market players to invest in these countries.

Epigenetics Technologies Market, by Region, 2022 (USD Million)

Epigenetics applications in metabolic diseases, oncology, and Immunology to drive the market growth for Epigenetics

Oncology

Oncology is one of those applications where epigenetics technology is extensively used for deriving therapeutic strategies designed to reverse transcriptional abnormalities inherent to the cancer epigenome. The disruption of epigenetic modifications, such as DNA methylation and histone modification, results in altered gene function or expression and cellular transformation leading cancer. Epigenetics assists in the development of inhibitors of DNA methyltransferases and histone deacetylases (HDACs), which have been found to be clinically effective in cancer treatment, attesting to the value of epigenetic therapies in oncology.

Non-Oncology

With the major hold of epigenetics in oncology, it is also being used to study modifications in various other applications, such as cardiovascular, neurodegenerative, autoimmune, and metabolic diseases. These diseases involve epigenetic modifications which can be counteracted by epigenetic treatments. These modifications seem an ideal target because they are reversible, unlike DNA sequence mutations. The most popular of these treatments aim to alter either DNA methylation or histone acetylation. Thus, a comprehensive understanding of epigenetic mechanisms and their interactions and alterations in health and diseases has become a priority in biomedical research.

Critical questions the report answers:

  • Where will all the factors shaping this technology market, take it in the next five years?
  • What are the upcoming applications for epigenetics?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Instruments required for epigenetics research are expensive as they are equipped with advanced features and functionalities. For instance, Illumina’s NovaSeq 5000 and 6000 sequencers (launched in January 2017) are priced at USD 850,000 and USD 985,000, respectively. In addition, maintenance and several other indirect expenses, such as sample and consumables, further increase the overall cost of ownership.

Pharmaceutical companies and research laboratories require many such systems. Therefore, significant investments are required for procuring multiple, high-cost genomic instruments. End users such as academic research laboratories find it difficult to afford such systems as they have constricted budgets. High instrument costs, therefore, hinder their wide adoption, which is expected to restrict market growth during the forecast period.

The global epigenetics market is characterized by a large number of players. The prominent players of this market are Illumina (US), Thermo Fisher (US), Diagenode (Belgium), QIAGEN (Netherlands), Merck Millipore (US), Abcam (UK), Active Motif (US), New England Biolabs (US), Agilent (US), Zymo Research (US), PerkinElmer (US), Bio-Rad (US). These companies are pursuing several organic and inorganic growth strategies such as acquisitions, collaboration, partnerships, agreements, expansions, and product launches.

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
           1.3.3 Currency
    1.4 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Approach
           2.1.1 Secondary Sources
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Sources
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 28)

4 Premium Insights (Page No. - 32)
    4.1 Epigenetics Market: Overview
    4.2 Global Market for Epigenetics: Developed vs Developing Countries
    4.3 Geographic Snapshot: Market (2016)
    4.4 Geographic Mix: Market
    4.5 APAC: Market, By Technology
    4.6 Global Market for Epigenetics: Size, By Kits (2017 vs 2022)

5 Market Overview (Page No. - 38)
    5.1 Introduction
    5.2 Key Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Declining Sequencing Costs and Time
                    5.2.1.2 Increasing Research Activities and Availability of Government Funding
                    5.2.1.3 Rising Cancer Prevalence
           5.2.2 Market Restraints
                    5.2.2.1 High Cost of Instruments
           5.2.3 Market Opportunities
                    5.2.3.1 High Growth Potential in Emerging Markets
                    5.2.3.2 Growing Applications of Epigenetics in Personalized Medicine and Targeted Therapy
                    5.2.3.3 Use of Epigenetics in Non-Oncology Applications
           5.2.4 Market Challenges
                    5.2.4.1 Dearth of Trained Professionals
                    5.2.4.2 Concerns Regarding the Quality of Antibodies

6 Epigenetics Market, By Product (Page No. - 44)
    6.1 Introduction
    6.2 Kits
           6.2.1 Chip-Seq Kits
           6.2.2 Bisulfite Conversion Kits
           6.2.3 Whole-Genome Amplification Kits
           6.2.4 5-HMC and 5-MC Analysis Kits
           6.2.5 RNA Sequencing Kits
           6.2.6 Other Epigenetics Kits
    6.3 Reagents
           6.3.1 Antibodies
           6.3.2 Magnetic Beads
           6.3.3 Histones
           6.3.4 Buffers
           6.3.5 Primers
           6.3.6 Other Epigenetics Reagents
    6.4 Enzymes
           6.4.1 DNA-Modifying Enzymes
           6.4.2 Protein-Modifying Enzymes
           6.4.3 RNA-Modifying Enzymes
    6.5 Instruments and Consumables
           6.5.1 Next-Generation Sequencers
           6.5.2 Qpcr Instruments
           6.5.3 Mass Spectrometers
           6.5.4 Sonicators
           6.5.5 Other Instruments and Consumables
    6.6 Bioinformatics Tools

7 Epigenetics Market, By Application (Page No. - 69)
    7.1 Introduction
    7.2 Oncology
    7.3 Metabolic Diseases
    7.4 Developmental Biology
    7.5 Immunology
    7.6 Cardiovascular Diseases
    7.7 Other Applications

8 Epigenetics Market, By Technology (Page No. - 78)
    8.1 Introduction
    8.2 DNA Methylation
    8.3 Histone Modification
    8.4 Other Technologies

9 Epigenetics Market, By End User (Page No. - 84)
    9.1 Introduction
    9.2 Academic and Research Institutes
    9.3 Pharmaceutical and Biotechnology Companies
    9.4 Contract Research Organizations

10 Epigenetics Market, By Region (Page No. - 90)
     10.1 Introduction
     10.2 North America
             10.2.1 US
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 UK
             10.3.3 France
             10.3.4 Italy
             10.3.5 Spain
             10.3.6 Rest of Europe
     10.4 Asia Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 Rest of Asia Pacific
     10.5 Latin America
     10.6 Middle East and Africa

11 Competitive Landscape (Page No. - 161)
     11.1 Introduction
     11.2 Market Share Analysis (2016)
     11.3 Competitive Situations & Trends
             11.3.1 Product Launches & Enhancement
             11.3.2 Acquisitions
             11.3.3 Agreements, Collaborations, and Partnerships
             11.3.4 Expansions
             11.3.5 Other Developments

12 Company Profiles (Page No. - 169)
(Business Overview, Products and Services, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments)
     12.1 Illumina
     12.2 Thermo Fisher Scientific
     12.3 Merck Millipore
     12.4 Abcam
     12.5 Active Motif
     12.6 Bio-Rad
     12.7 New England Biolabs
     12.8 Agilent
     12.9 Qiagen
     12.10 Zymo Research
     12.11 Perkinelmer
     12.12 Diagenode

13 Appendix (Page No. - 222)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Introducing RT: Real-Time Market Intelligence
     13.4 Available Customizations
     13.5 Related Reports


List of Tables (191 Tables)

Table 1 Global Epigenetics Market, By Product, 2015–2022 (USD Million)
Table 2 Global Epigenetics Kits Market, By Type, 2015–2022 (USD Million)
Table 3 Global Epigenetics Kits Market, By Country/Region, 2015–2022 (USD Million)
Table 4 Global Chip-Seq Kits Market, By Country/Region, 2015–2022 (USD Million)
Table 5 Global Bisulfite Conversion Kits Market, By Country/Region, 2015–2022 (USD Million)
Table 6 Global Whole-Genome Amplification Kits Market, By Country/Region, 2015–2022 (USD Million)
Table 7 Global 5-HMC and 5-MC Analysis Kits Market, By Country/Region, 2015–2022 (USD Million)
Table 8 Global RNA Sequencing Kits Market, By Country/Region, 2015–2022 (USD Million)
Table 9 Global Other Epigenetics Kits Market, By Country/Region, 2015–2022 (USD Million)
Table 10 Global Epigenetics Reagents Market, By Type, 2015–2022 (USD Million)
Table 11 Global Epigenetics Reagents Market, By Country/Region, 2015–2022 (USD Million)
Table 12 Global Antibodies Market, By Country/Region, 2015–2022 (USD Million)
Table 13 Global Magnetic Beads Market, By Country/Region, 2015–2022 (USD Million)
Table 14 Global Histones Market, By Country/Region, 2015–2021 (USD Million)
Table 15 Global Buffers Market, By Country/Region, 2015–2022 (USD Million)
Table 16 Global Primers Market, By Country/Region, 2015–2022 (USD Million)
Table 17 Global Other Epigenetics Reagents Market, By Country/Region, 2015–2022 (USD Million)
Table 18 Global Epigenetics Enzymes Market, By Type, 2015–2022 (USD Million)
Table 19 Global Epigenetics Enzymes Market, By Country/Region, 2015–2022 (USD Million)
Table 20 Global DNA-Modifying Enzymes Market, By Country/Region, 2015–2022 (USD Million)
Table 21 Global Protein-Modifying Enzymes Market, By Country/Region, 2015–2022 (USD Million)
Table 22 Global RNA-Modifying Enzymes Market, By Country/Region, 2015–2022 (USD Million)
Table 23 Global Epigenetics Instruments and Consumables Market, By Type, 2015–2022 (USD Million)
Table 24 Global Epigenetics Instruments and Consumables Market, By Country/Region, 2015–2022 (USD Million)
Table 25 Global Next-Generation Sequencers Market, By Country/Region, 2015–2022 (USD Million)
Table 26 Global Qpcr Instruments Market, By Country/Region, 2015–2022 (USD Million)
Table 27 Global Mass Spectrometers Market, By Country/Region, 2015–2022 (USD Million)
Table 28 Global Sonicators Market, By Country/Region, 2015–2022 (USD Million)
Table 29 Global Other Instruments and Consumables Market, By Country/Region, 2015–2022 (USD Million)
Table 30 Global Bioinformatics Tools Market, By Country/Region, 2015–2022 (USD Million)
Table 31 Global Epigenetics Market, By Application, 2015–2022 (USD Million)
Table 32 Epigenome-Targeting Cancer Drugs Approved Or in Clinical Trials
Table 33 Global Market for Oncology, By Country/Region, 2015–2022 (USD Million)
Table 34 Global Market for Metabolic Diseases, By Country/Region, 2015–2022 (USD Million)
Table 35 Global Market for Developmental Biology, By Country/Region, 2015–2022 (USD Million)
Table 36 Global Market for Immunology, By Country/Region, 2015–2022 (USD Million)
Table 37 Global Epigenetics Market for Cardiovascular Diseases, By Country/Region, 2015–2022 (USD Million)
Table 38 Global Market for Other Applications, By Country/Region, 2015–2022 (USD Million)
Table 39 Global Market, By Technology, 2015–2022 (USD Million)
Table 40 Global DNA Methylation Market, By Country/Region, 2015–2022 (USD Million)
Table 41 Global Histone Modification Market, By Country/Region, 2015–2022 (USD Million)
Table 42 Global Other Technologies Market, By Country/Region, 2015–2022 (USD Million)
Table 43 Global Epigenetics Market, By End User, 2015–2022 (USD Million)
Table 44 Global Market for Academic and Research Institutes, By Country/Region, 2015–2022 (USD Million)
Table 45 Global Market for Epigenetics: for Pharmaceutical and Biotechnology Companies, By Country/Region, 2015–2022 (USD Million)
Table 46 Global Market for Contract Research Organizations, By Country/Region, 2015–2022 (USD Million)
Table 47 Epigenetics Market, By Region, 2015–2022 (USD Million)
Table 48 North America: Market, By Country, 2015–2022 (USD Million)
Table 49 North America: Market, By Product, 2015–2022 (USD Million)
Table 50 North America: Epigenetics Kits Market, By Type, 2015–2022 (USD Million)
Table 51 North America: Epigenetics Reagents Market, By Type, 2015–2022 (USD Million)
Table 52 North America: Epigenetics Enzymes Market, By Type, 2015–2022 (USD Million)
Table 53 North America: Epigenetics Instruments and Consumables Market, By Type, 2015–2022 (USD Million)
Table 54 North America: Epigenetics Market, By Application, 2015–2022 (USD Million)
Table 55 North America: Epigenetics Market, By Technology, 2015–2022 (USD Million)
Table 56 North America: Market, By End User, 2015–2022 (USD Million)
Table 57 US: Market, By Product, 2015–2022 (USD Million)
Table 58 US: Epigenetics Kits Market, By Type, 2015–2022 (USD Million)
Table 59 US: Epigenetics Reagents Market, By Type, 2015–2022 (USD Million)
Table 60 US: Epigenetics Enzymes Market, By Type, 2015–2022 (USD Million)
Table 61 US: Epigenetics Instruments and Consumables Market, By Type, 2015–2022 (USD Million)
Table 62 US: Epigenetics Market, By Application, 2015–2022 (USD Million)
Table 63 US: Market, By Technology, 2015–2022 (USD Million)
Table 64 US: Market, By End User, 2015–2022 (USD Million)
Table 65 Canada: Market, By Product, 2015–2022 (USD Million)
Table 66 Canada: Epigenetics Kits Market, By Type, 2015–2022 (USD Million)
Table 67 Canada: Epigenetics Reagents Market, By Type, 2015–2022 (USD Million)
Table 68 Canada: Epigenetics Enzymes Market, By Type, 2015–2022 (USD Million)
Table 69 Canada: Epigenetics Instruments and Consumables Market, By Type, 2015–2022 (USD Million)
Table 70 Canada: Epigenetics Market, By Application, 2015–2022 (USD Million)
Table 71 Canada: Market, By Technology, 2015–2022 (USD Million)
Table 72 Canada: Market, By End User, 2015–2022 (USD Million)
Table 73 Europe: Market, By Country, 2015–2022 (USD Million)
Table 74 Europe: Market, By Product, 2015–2022 (USD Million)
Table 75 Europe: Epigenetics Kits Market, By Type, 2015–2022 (USD Million)
Table 76 Europe: Epigenetics Reagents Market, By Type, 2015–2022 (USD Million)
Table 77 Europe: Epigenetics Enzymes Market, By Type, 2015–2022 (USD Million)
Table 78 Europe: Epigenetics Instruments and Consumables Market, By Type, 2015–2022 (USD Million)
Table 79 Europe: Epigenetics Market, By Application, 2015–2022 (USD Million)
Table 80 Europe: Market, By Technology, 2015–2022 (USD Million)
Table 81 Europe: Market, By End User, 2015–2022 (USD Million)
Table 82 Germany: Market, By Product, 2015–2022 (USD Million)
Table 83 Germany: Epigenetics Kits Market, By Type, 2015–2022 (USD Million)
Table 84 Germany: Epigenetics Reagents Market, By Type, 2015–2022 (USD Million)
Table 85 Germany: Epigenetics Enzymes Market, By Type, 2015–2022 (USD Million)
Table 86 Germany: Epigenetics Instruments and Consumables Market, By Type, 2015–2022 (USD Million)
Table 87 Germany: Epigenetics Market, By Application, 2015–2022 (USD Million)
Table 88 Germany: Market, By Technology, 2015–2022 (USD Million)
Table 89 Germany: Market, By End User, 2015–2022 (USD Million)
Table 90 UK: Market, By Product, 2015–2022 (USD Million)
Table 91 UK: Epigenetics Kits Market, By Type, 2015–2022 (USD Million)
Table 92 UK: Epigenetics Reagents Market, By Type, 2015–2022 (USD Million)
Table 93 UK: Epigenetics Enzymes Market, By Type, 2015–2022 (USD Million)
Table 94 UK: Epigenetics Instruments and Consumables Market, By Type, 2015–2022 (USD Million)
Table 95 UK: Market, By Application, 2015–2022 (USD Million)
Table 96 UK: Market, By Technology, 2015–2022 (USD Million)
Table 97 UK: Market, By End User, 2015–2022 (USD Million)
Table 98 France: Epigenetics Market, By Product, 2015–2022 (USD Million)
Table 99 France: Epigenetics Kits Market, By Type, 2015–2022 (USD Million)
Table 100 France: Epigenetics Reagents Market, By Type, 2015–2022 (USD Million)
Table 101 France: Epigenetics Enzymes Market, By Type, 2015–2022 (USD Million)
Table 102 France: Epigenetics Instruments and Consumables Market, By Type, 2015–2022 (USD Million)
Table 103 France: Epigenetics Market, By Application, 2015–2022 (USD Million)
Table 104 France: Market, By Technology, 2015–2022 (USD Million)
Table 105 France: Market, By End User, 2015–2022 (USD Million)
Table 106 Italy: Market, By Product, 2015–2022 (USD Million)
Table 107 Italy: Epigenetics Kits Market, By Type, 2015–2022 (USD Million)
Table 108 Italy: Epigenetics Reagents Market, By Type, 2015–2022 (USD Million)
Table 109 Italy: Epigenetics Enzymes Market, By Type, 2015–2022 (USD Million)
Table 110 Italy: Epigenetics Instruments and Consumables Market, By Type, 2015–2022 (USD Million)
Table 111 Italy: Market, By Application, 2015–2022 (USD Million)
Table 112 Italy: Market, By Technology, 2015–2022 (USD Million)
Table 113 Italy: Market, By End User, 2015–2022 (USD Million)
Table 114 Spain: Epigenetics Market, By Product, 2015–2022 (USD Million)
Table 115 Spain: Epigenetics Kits Market, By Type, 2015–2022 (USD Million)
Table 116 Spain: Epigenetics Reagents Market, By Type, 2015–2022 (USD Million)
Table 117 Spain: Epigenetics Enzymes Market, By Type, 2015–2022 (USD Million)
Table 118 Spain: Epigenetics Instruments and Consumables Market, By Type, 2015–2022 (USD Million)
Table 119 Spain: Market, By Application, 2015–2022 (USD Million)
Table 120 Spain: Market for Epigenetics, By Technology, 2015–2022 (USD Million)
Table 121 Spain: Market, By End User, 2015–2022 (USD Million)
Table 122 RoE: Market, By Product, 2015–2022 (USD Million)
Table 123 RoE: Epigenetics Kits Market, By Type, 2015–2022 (USD Million)
Table 124 RoE: Epigenetics Reagents Market, By Type, 2015–2022 (USD Million)
Table 125 RoE: Epigenetics Enzymes Market, By Type, 2015–2022 (USD Million)
Table 126 RoE: Epigenetics Instruments and Consumables Market, By Type, 2015–2022 (USD Million)
Table 127 RoE: Epigenetics Market, By Application, 2015–2022 (USD Million)
Table 128 RoE: Market for Epigenetics, By Technology, 2015–2022 (USD Million)
Table 129 RoE: Market, By End User, 2015–2022 (USD Million)
Table 130 Asia Pacific: Market, By Country, 2015–2022 (USD Million)
Table 131 Asia Pacific: Market, By Product, 2015–2022 (USD Million)
Table 132 Asia Pacific: Epigenetics Kits Market, By Type, 2015–2022 (USD Million)
Table 133 Asia Pacific: Epigenetics Reagents Market, By Type, 2015–2022 (USD Million)
Table 134 Asia Pacific: Epigenetics Enzymes Market, By Type, 2015–2022 (USD Million)
Table 135 Asia Pacific: Epigenetics Instruments and Consumables Market, By Type, 2015–2022 (USD Million)
Table 136 Asia Pacific: Epigenetics Market, By Application, 2015–2022 (USD Million)
Table 137 Asia Pacific: Market for Epigenetics, By Technology, 2015–2022 (USD Million)
Table 138 Asia Pacific: Market, By End User, 2015–2022 (USD Million)
Table 139 Japan: Market, By Product, 2015–2022 (USD Million)
Table 140 Japan: Epigenetics Kits Market, By Type, 2015–2022 (USD Million)
Table 141 Japan: Epigenetics Reagents Market, By Type, 2015–2022 (USD Million)
Table 142 Japan: Epigenetics Enzymes Market, By Type, 2015–2022 (USD Million)
Table 143 Japan: Epigenetics Instruments and Consumables Market, By Type, 2015–2022 (USD Million)
Table 144 Japan: Epigenetics Market, By Application, 2015–2022 (USD Million)
Table 145 Japan: Market for Epigenetics, By Technology, 2015–2022 (USD Million)
Table 146 Japan: Market, By End User, 2015–2022 (USD Million)
Table 147 China: Market, By Product, 2015–2022 (USD Million)
Table 148 China: Epigenetics Kits Market, By Type, 2015–2022 (USD Million)
Table 149 China: Epigenetics Reagents Market, By Type, 2015–2022 (USD Million)
Table 150 China: Epigenetics Enzymes Market, By Type, 2015–2022 (USD Million)
Table 151 China: Epigenetics Instruments and Consumables Market, By Type, 2015–2022 (USD Million)
Table 152 China: Epigenetics Market, By Application, 2015–2022 (USD Million)
Table 153 China: Market for Epigenetics, By Technology, 2015–2022 (USD Million)
Table 154 China: Market, By End User, 2015–2022 (USD Million)
Table 155 India: Market, By Product, 2015–2022 (USD Million)
Table 156 India: Epigenetics Kits Market, By Type, 2015–2022 (USD Million)
Table 157 India: Epigenetics Reagents Market, By Type, 2015–2022 (USD Million)
Table 158 India: Epigenetics Enzymes Market, By Type, 2015–2022 (USD Million)
Table 159 India: Epigenetics Instruments and Consumables Market, By Type, 2015–2022 (USD Million)
Table 160 India: Epigenetics Market, By Application, 2015–2022 (USD Million)
Table 161 India: Market for Epigenetics, By Technology, 2015–2022 (USD Million)
Table 162 India: Market, By End User, 2015–2022 (USD Million)
Table 163 RoAPAC: Market, By Product, 2015–2022 (USD Million)
Table 164 RoAPAC: Epigenetics Kits Market, By Type, 2015–2022 (USD Million)
Table 165 RoAPAC: Epigenetics Reagents Market, By Type, 2015–2022 (USD Million)
Table 166 RoAPAC: Epigenetics Enzymes Market, By Type, 2015–2022 (USD Million)
Table 167 RoAPAC: Epigenetics Instruments and Consumables Market, By Type, 2015–2022 (USD Million)
Table 168 RoAPAC: Epigenetics Market, By Application, 2015–2022 (USD Million)
Table 169 RoAPAC: Market for Epigenetics, By Technology, 2015–2022 (USD Million)
Table 170 RoAPAC: Market, By End User, 2015–2022 (USD Million)
Table 171 Latin America: Market, By Product, 2015–2022 (USD Million)
Table 172 Latin America: Epigenetics Kits Market, By Type, 2015–2022 (USD Million)
Table 173 Latin America: Epigenetics Reagents Market, By Type, 2015–2022(USD Million)
Table 174 Latin America: Epigenetics Enzymes Market, By Type, 2015–2022 (USD Million)
Table 175 Latin America: Epigenetics Instruments and Consumables Market, By Type, 2015–2022 (USD Million)
Table 176 Latin America: Epigenetics Market, By Application, 2015–2022 USD Million)
Table 177 Latin America: Market for Epigenetics, By Technology, 2015–2022 (USD Million)
Table 178 Latin America: Epigenetics Market, By End User, 2015–2022 (USD Million)
Table 179 Middle East and Africa: Epigenetics Market, By Product, 2015–2022 (USD Million)
Table 180 Middle East and Africa: Epigenetics Kits Market, By Type, 2015–2022 (USD Million)
Table 181 Middle East and Africa: Epigenetics Reagents Market, By Type, 2015–2022 (USD Million)
Table 182 Middle East and Africa: Epigenetics Enzymes Market, By Type, 2015–2022 (USD Million)
Table 183 Middle East and Africa: Epigenetics Instruments and Consumables Market, By Type, 2015–2022 (USD Million)
Table 184 Middle East and Africa: Market for Epigenetics, By Application, 2015–2022 (USD Million)
Table 185 Middle East and Africa: Epigenetics Market, By Technology, 2015–2022 (USD Million)
Table 186 Middle East and Africa: Epigenetics Market, By End User, 2015–2022 (USD Million)
Table 187 New Product Launches and Enhancements, 2014–2017
Table 188 Acquisitions, 2014–2017
Table 189 Agreements, Collaborations and Partnerships, 2014–2017
Table 190 Expansions, 2014–2017
Table 191 Other Developments, 2014–2017


List of Figures (37 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Global Epigenetics Market, By Product, 2017 vs 2022 (USD Billion)
Figure 7 Global Epigenetics Market, By Application, 2017 vs 2022 (USD Billion)
Figure 8 Global Market, By Technology, 2017 vs 2022 (USD Billion)
Figure 9 Global Market, By End User, 2017 vs 2022 (USD Billion)
Figure 10 Geographic Snapshot: Market
Figure 11 Declining Sequencing Costs, Increasing Research Activities, and Rising Cancer Prevalence—Key Market Drivers
Figure 12 Developing Markets to Register Higher Growth in the Forecast Period
Figure 13 US Accounted for the Largest Share of the Epigenetics Market in 2016
Figure 14 North America to Dominate the Epigenetics Market During the Forecast Period
Figure 15 DNA Methylation Comanded the Largest Share of the APAC Epigenetics Technology Market in 2016
Figure 16 Chip-Seq Kits Dominates the Epigenetics Kits Market in 2017
Figure 17 Epigenetics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Sequencing Cost Per Genome, 2001–2015 (USD Million)
Figure 19 Kits Segment to Command the Largest Share of the Epigenetics Products Market in 2017
Figure 20 Oncology Segment to Command the Largest Share of the Epigenetics Application Market in 2017
Figure 21 DNA Methylation Segment to Command the Largest Share of the Epigenetics Market in 2017
Figure 22 Academic and Research Institutes Segment to Account for the Largest Share of the Epigenetics Market, By End User, in 2017
Figure 23 Market: Geographic Growth Opportunities
Figure 24 North America: Market Snapshot
Figure 25 Asia Pacific: Market Snapshot
Figure 26 Global Market Share Analysis, By Key Player, 2016
Figure 27 Epigenetics Market (Global), Competitive Leadership Mapping, 2017
Figure 28 Illumina: Company Snapshot (2016)
Figure 29 Thermo Fisher Scientific: Company Snapshot (2016)
Figure 30 Merck Millipore: Company Snapshot (2016)
Figure 31 Abcam: Company Snapshot (2016)
Figure 32 Bio-Rad Laboratories: Company Snapshot (2016)
Figure 33 Agilent: Company Snapshot (2016)
Figure 34 Qiagen: Company Snapshot (2016)
Figure 35 Perkinelmer: Company Snapshot (2016)
Figure 36 Knowledge Store Snapshot
Figure 37 Knowledge Store: Healthcare Industry Snapshot


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
BT 2775
Published ON
Oct, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Epigenetics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home